School of Nursing, Dalian Medical University, Dalian, China.
School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong, China.
Oncologist. 2023 Apr 6;28(4):e175-e182. doi: 10.1093/oncolo/oyac267.
Since the COVID-19 pandemic, there have been an increasing number of studies on using mobile health (mHealth) to support the symptom self-management of patients with breast cancer (BC). However, the components of such programs remain unexplored. This systematic review aimed to identify the components of existing mHealth app-based interventions for patients with BC who are undergoing chemotherapy and to uncover self-efficacy enhancement elements from among them.
A systematic review was conducted for randomized controlled trials published from 2010 to 2021. Two strategies were used to assess the mHealth apps: The Omaha System, a structured classification system for patient care, and Bandura's self-efficacy theory, which assesses sources of influence that determine an individual's confidence in being able to manage a problem. Intervention components identified in the studies were grouped under the 4 domains of the intervention scheme of the Omaha System. Four hierarchical sources of self-efficacy enhancement elements were extracted from the studies using Bandura's self-efficacy theory.
The search uncovered 1,668 records. Full-text screening was conducted on 44 articles, and 5 randomized controlled trials (n = 537 participants) were included. Self-monitoring under the domain of "Treatments and procedure" was the most frequently used mHealth intervention for improving symptom self-management in patients with BC undergoing chemotherapy. Most mHealth apps used various "mastery experience" strategies including reminders, self-care advice, videos, and learning forums.
Self-monitoring was commonly utilized in mHealth-based interventions for patients with BC undergoing chemotherapy. Our survey uncovered evident variation in strategies to support self-management of symptoms and standardized reporting is required. More evidence is required to make conclusive recommendations related to mHealth tools for BC chemotherapy self-management.
自 COVID-19 大流行以来,越来越多的研究使用移动健康(mHealth)来支持乳腺癌(BC)患者的症状自我管理。然而,这些项目的组成部分仍未得到探索。本系统评价旨在确定正在接受化疗的 BC 患者基于移动健康应用程序的干预措施的现有组成部分,并从中发现自我效能增强要素。
对 2010 年至 2021 年发表的随机对照试验进行了系统评价。使用了两种策略来评估 mHealth 应用程序:奥马哈系统,这是一种针对患者护理的结构化分类系统,以及班杜拉的自我效能理论,该理论评估了确定个体管理问题的信心的影响来源。研究中确定的干预组成部分根据奥马哈系统的干预方案的 4 个领域进行了分组。使用班杜拉的自我效能理论,从研究中提取了四个层次的自我效能增强要素来源。
搜索共发现 1668 条记录。对 44 篇文章进行了全文筛选,纳入了 5 项随机对照试验(n = 537 名参与者)。在“治疗和程序”领域进行自我监测是改善正在接受化疗的 BC 患者症状自我管理的最常用 mHealth 干预措施。大多数 mHealth 应用程序使用了各种“掌握经验”策略,包括提醒、自我护理建议、视频和学习论坛。
在正在接受化疗的 BC 患者的基于 mHealth 的干预措施中,自我监测被广泛使用。我们的调查发现,支持症状自我管理的策略存在明显差异,需要进行标准化报告。需要更多的证据来提出关于 BC 化疗自我管理的 mHealth 工具的明确建议。